Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guizard

Showing results (161-170 of 178) with videos related to

Pageof 18
Sort By:
European Journal of Nutrition|October 31, 2021
Adapted dietary inflammatory index and differentiated thyroid carcinoma risk in two French population-based case-control studiesLucie Lécuyer, Nasser Laouali, Mariem Hajji-Louati, et al.
Cancer Causes & Control : CCC|January 26, 2022
To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based studyZoéwendtalé Cyrille Compaoré, Elisabeth Monnet, Aurélie Gérazime, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2018
Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patientsE Jacquet, A Lardy-Cléaud, B Pistilli, et al.
Pediatric Blood & Cancer|May 18, 2018
Adolescent and young adult oncology patients in France: Heterogeneity in pathways of careEmmanuel Desandes, Laurence Brugières, Florence Molinié, et al.
Journal of Adolescent and Young Adult Oncology|May 16, 2020
Cancer Among Adolescents and Young Adults Between 2000 and 2016 in France: Incidence and Improved SurvivalThomas Raze, Brigitte Lacour, Anne Cowppli-Bony, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2006
Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM)N Bossard, M Velten, L Remontet, et al.
BMJ Open|February 24, 2019
The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)David Pérol, Mathieu Robain, Patrick Arveux, et al.
International Journal of Cancer|July 2, 2009
Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005N Le Stang, A Belot, A Gilg Soit Ilg, et al.
Oncotarget|March 22, 2021
Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 2q35 and 8p12 in Europeans, Melanesians and PolynesiansJulie Guibon, Pierre-Emmanuel Sugier, Om Kulkarni, et al.
Revue D'Epidemiologie Et De Sante Publique|April 10, 2003
Cancer incidence and mortality in France over the period 1978-2000L Remontet, J Estève, A-M Bouvier, et al.
Pageof 18

Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
European Journal of Nutrition|October 31, 2021
Adapted dietary inflammatory index and differentiated thyroid carcinoma risk in two French population-based case-control studiesLucie Lécuyer, Nasser Laouali, Mariem Hajji-Louati, et al.
Cancer Causes & Control : CCC|January 26, 2022
To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based studyZoéwendtalé Cyrille Compaoré, Elisabeth Monnet, Aurélie Gérazime, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2018
Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patientsE Jacquet, A Lardy-Cléaud, B Pistilli, et al.
Pediatric Blood & Cancer|May 18, 2018
Adolescent and young adult oncology patients in France: Heterogeneity in pathways of careEmmanuel Desandes, Laurence Brugières, Florence Molinié, et al.
Journal of Adolescent and Young Adult Oncology|May 16, 2020
Cancer Among Adolescents and Young Adults Between 2000 and 2016 in France: Incidence and Improved SurvivalThomas Raze, Brigitte Lacour, Anne Cowppli-Bony, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2006
Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM)N Bossard, M Velten, L Remontet, et al.
BMJ Open|February 24, 2019
The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)David Pérol, Mathieu Robain, Patrick Arveux, et al.
International Journal of Cancer|July 2, 2009
Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005N Le Stang, A Belot, A Gilg Soit Ilg, et al.
Oncotarget|March 22, 2021
Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 2q35 and 8p12 in Europeans, Melanesians and PolynesiansJulie Guibon, Pierre-Emmanuel Sugier, Om Kulkarni, et al.
Revue D'Epidemiologie Et De Sante Publique|April 10, 2003
Cancer incidence and mortality in France over the period 1978-2000L Remontet, J Estève, A-M Bouvier, et al.
Pageof 18